Quarterly Results Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
995.30
1,041.26
979.94
805.17
974.37
949.42
1,010.77
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
995.30
1,041.26
979.94
805.17
974.37
949.42
1,010.77
Raw Material Cost
113.06
79.90
115.13
128.06
115.23
97.48
148.96
Purchase of Finished goods
228.40
217.27
232.72
232.06
291.40
164.23
216.74
(Increase) / Decrease In Stocks
2.54
66.65
7.68
-72.41
-54.69
97.45
18.79
Employee Cost
164.75
151.88
138.05
152.57
152.97
124.74
150.71
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
135.62
154.22
150.63
113.69
136.27
173.60
153.86
Total Expenditure (Excl Depreciation)
644.37
669.92
644.21
553.97
641.18
657.50
689.06
Operating Profit (PBDIT) excl Other Income
350.93
371.34
335.73
251.20
333.19
291.92
321.71
Other Income
35.95
32.12
33.57
43.72
40.68
35.07
34.54
Operating Profit (PBDIT)
386.88
403.46
369.30
294.92
373.87
326.99
356.25
Interest
0.61
1.19
0.51
0.42
0.58
0.09
0.27
Exceptional Items
0.00
17.98
2.64
0.00
0.00
0.00
4.69
Gross Profit (PBDT)
386.27
420.25
371.43
294.50
373.29
326.90
360.67
Depreciation
13.17
20.32
17.43
15.52
14.72
18.80
16.86
Profit Before Tax
373.10
399.93
354.00
278.98
358.57
308.10
343.81
Tax
95.24
104.31
96.51
73.97
95.70
78.22
91.31
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
277.86
295.62
257.49
205.01
262.87
229.88
252.50
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
277.86
295.62
257.49
205.01
262.87
229.88
252.50
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
277.86
295.62
257.49
205.01
262.87
229.88
252.50
Equity Capital
169.41
169.41
169.41
169.41
169.41
169.41
169.41
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
16.4
17.45
15.2
12.1
15.52
13.57
14.9
Diluted Earnings per share
16.4
17.45
15.02
12.1
15.52
13.57
14.91
Operating Profit Margin (Excl OI)
35.26%
35.66%
34.26%
31.2%
34.2%
30.75%
31.83%
Gross Profit Margin
38.81%
40.36%
37.9%
36.58%
38.31%
34.43%
35.68%
PAT Margin
27.92%
28.39%
26.28%
25.46%
26.98%
24.21%
24.98%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Mar 2026 is -4.41% vs 6.26% in Dec 2025
Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is -6.01% vs 14.81% in Dec 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Mar 2026 is -5.50% vs 10.61% in Dec 2025
Interest
QoQ Growth in quarter ended Mar 2026 is -48.74% vs 133.33% in Dec 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025
Compare Quarterly Results Of Glaxosmi. Pharma With
Figures in Cr
Consolidate Quarterly Results
Change(INR)
Change(%)
Net Sales
995.30
2,392.50
-1,397.20
-58.40%
Other Operating Income
0.00
0.00
0.00
Total Operating income
995.30
2,392.50
-1,397.20
-58.40%
Raw Material Cost
113.06
564.44
-451.38
-79.97%
Purchase of Finished goods
228.40
129.83
98.57
75.92%
(Increase) / Decrease In Stocks
2.54
-36.37
38.91
106.98%
Employee Cost
164.75
546.09
-381.34
-69.83%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
135.62
655.16
-519.54
-79.30%
Total Expenditure (Excl Depreciation)
644.37
1,859.15
-1,214.78
-65.34%
Operating Profit (PBDIT) excl Other Income
350.93
533.35
-182.42
-34.20%
Other Income
35.95
20.19
15.76
78.06%
Operating Profit (PBDIT)
386.88
553.54
-166.66
-30.11%
Interest
0.61
17.62
-17.01
-96.54%
Exceptional Items
0.00
17.65
-17.65
-100.00%
Gross Profit (PBDT)
386.27
553.57
-167.30
-30.22%
Depreciation
13.17
107.59
-94.42
-87.76%
Profit Before Tax
373.10
445.98
-72.88
-16.34%
Tax
95.24
81.93
13.31
16.25%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
277.86
364.05
-86.19
-23.68%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
277.86
364.05
-86.19
-23.68%
Share in Profit of Associates
0.00
-0.38
0.38
100.00%
Minority Interest
0.00
37.40
-37.40
-100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
277.86
326.27
-48.41
-14.84%
Equity Capital
169.41
25.37
144.04
567.76%
Face Value
10.00
1.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
16.40
12.86
3.54
27.53%
Diluted Earnings per share
16.40
12.86
3.54
27.53%
Operating Profit Margin (Excl OI)
35.26%
22.29%
0.00
12.97%
Gross Profit Margin
38.81%
23.14%
0.00
15.67%
PAT Margin
27.92%
15.22%
0.00
12.70%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 995.30 Cr
in Mar 2026Figures in Cr
QoQ Growth in quarter ended Mar 2026 is -4.41% vs 6.26% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 2.15% vs 4.79% in Mar 2025
Quarterly - Consolidate Net Profit
Consolidate Net Profit 277.86 Cr
in Mar 2026Figures in Cr
QoQ Growth in quarter ended Mar 2026 is -6.01% vs 14.81% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 5.70% vs 35.17% in Mar 2025
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 350.93 Cr
in Mar 2026Figures in Cr
QoQ Growth in quarter ended Mar 2026 is -5.50% vs 10.61% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 5.32% vs 29.51% in Mar 2025
Quarterly - Interest
Interest 0.61 Cr
in Mar 2026Figures in Cr
QoQ Growth in quarter ended Mar 2026 is -48.74% vs 133.33% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 5.17% vs -24.68% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 35.26%
in Mar 2026Figures in %
QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
